Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Sheng Wang

Showing results (1-10 of 429) with videos related to

Pageof 43
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 13, 2007
Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challengesFu-Sheng Wang
World Journal of Gastroenterology|April 8, 2003
Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infectionFu-Sheng Wang
Zhonghua Yi Xue Za Zhi|March 16, 2004
[Current status, limitations and prospects in clinical trials of cancer gene therapy]Fu-sheng Wang
Infectious Diseases & Immunity|June 22, 2026
Message from Editor-in-Chief: Write a New Chapter of <i>Infectious Diseases & Immunity</i> in Concerted EffortsFu-Sheng Wang
Zhonghua Yi Xue Za Zhi|July 21, 2005
[Curtain of HBV infection by host innate immunity and clinically associated therapeutic strategy for chronic HBV-infected individuals]Fu-sheng Wang
Infectious Diseases & Immunity|April 17, 2024
<i>IDI</i>: Building a Bridge of Communication Between China and Other Nations in the Field of Infectious DiseasesFu-Sheng Wang
Hepatology International|July 29, 2019
Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challengesLifeng Wang, Fu-Sheng Wang
Journal of Hepatology|January 29, 2013
Stem cell therapies for liver failure and cirrhosisZheng Zhang, Fu-Sheng Wang
Journal of Gastroenterology and Hepatology|September 29, 2011
Are non-traditional CD4(+) CD69(+) CD25(-) regulatory T cells involved in disease progression of human hepatocellular carcinoma?Dongping Xu, Fu-Sheng Wang
Lancet (London, England)|February 10, 2020
What to do next to control the 2019-nCoV epidemic?Fu-Sheng Wang, Chao Zhang
Pageof 43

Showing results (1-10 of 429) with videos related to

Sort By:
Pageof 43
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 13, 2007
Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challengesFu-Sheng Wang
World Journal of Gastroenterology|April 8, 2003
Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infectionFu-Sheng Wang
Zhonghua Yi Xue Za Zhi|March 16, 2004
[Current status, limitations and prospects in clinical trials of cancer gene therapy]Fu-sheng Wang
Infectious Diseases & Immunity|June 22, 2026
Message from Editor-in-Chief: Write a New Chapter of <i>Infectious Diseases & Immunity</i> in Concerted EffortsFu-Sheng Wang
Zhonghua Yi Xue Za Zhi|July 21, 2005
[Curtain of HBV infection by host innate immunity and clinically associated therapeutic strategy for chronic HBV-infected individuals]Fu-sheng Wang
Infectious Diseases & Immunity|April 17, 2024
<i>IDI</i>: Building a Bridge of Communication Between China and Other Nations in the Field of Infectious DiseasesFu-Sheng Wang
Hepatology International|July 29, 2019
Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challengesLifeng Wang, Fu-Sheng Wang
Journal of Hepatology|January 29, 2013
Stem cell therapies for liver failure and cirrhosisZheng Zhang, Fu-Sheng Wang
Journal of Gastroenterology and Hepatology|September 29, 2011
Are non-traditional CD4(+) CD69(+) CD25(-) regulatory T cells involved in disease progression of human hepatocellular carcinoma?Dongping Xu, Fu-Sheng Wang
Lancet (London, England)|February 10, 2020
What to do next to control the 2019-nCoV epidemic?Fu-Sheng Wang, Chao Zhang
Pageof 43